HUM

Humana
D

HUM

Arincen41/100B

Humana income statement 1990–2026

154.19B USD over the last twelve months, and 129.66B USD in fiscal year 2025.

Revenue Operating income Net income

Click a line's chart icon in the table to add it to the chart; hover over it for a quick look.

Fiscal year
TTM
30 Sept 2026
FY2025
31 Dec 2025
FY2024
31 Dec 2024
FY2023
31 Dec 2023
FY2022
31 Dec 2022
FY2021
31 Dec 2021
FY2020
31 Dec 2020
FY2019
31 Dec 2019
FY2018
31 Dec 2018
FY2017
31 Dec 2017
FY2016
31 Dec 2016
Revenue
154.19B129.66B117.81B106.44B92.92B83.65B77.19B64.93B56.94B53.80B54.41B
Revenue growth
+22.02%+10.06%+10.68%+14.55%+11.09%+8.37%+18.88%+14.03%+5.84%-1.11%+0.21%
Cost of revenue
134.12B110.81B100.66B88.39B75.69B69.20B61.50B53.74B45.75B43.39B44.90B
Gross profit
20.06B18.85B17.15B18.05B17.23B14.45B15.69B11.19B11.19B7.09B7.77B
Gross margin
13.01%14.54%14.55%16.95%18.54%17.27%20.33%17.24%19.65%13.17%14.28%
Selling, general and administrative
—0.000.000.000.000.000.000.000.000.000.00
Operating expenses
18.07B17.40B15.52B14.73B13.67B11.03B11.02B7.72B9.12B7.09B7.77B
1.99B1.45B1.63B3.32B3.56B3.42B4.67B3.47B2.07B3.33B1.74B
Operating income growth
+25.97%-10.69%-50.99%-6.85%+4.24%-26.85%+34.70%+67.31%-37.64%+91.04%-25.82%
Operating margin
1.29%1.12%1.38%3.12%3.84%4.09%6.06%5.34%3.64%6.18%3.20%
Interest expense
753.00M631.00M660.00M493.00M401.00M326.00M283.00M242.00M218.00M242.00M189.00M
Other non-operating income
—0.000.000.000.000.000.000.000.0010.41B9.51B
Pretax income
1.72B1.45B1.63B3.32B3.56B3.42B4.67B3.47B2.07B4.02B1.55B
Income tax
424.00M250.00M413.00M836.00M762.00M485.00M1.31B763.00M391.00M1.57B938.00M
Effective tax rate
24.62%17.21%25.38%25.18%21.38%14.19%27.96%21.99%18.85%39.10%60.44%
1.25B1.19B1.21B2.49B2.81B2.93B3.37B2.71B1.68B2.45B614.00M
Net income growth
-3.56%-1.57%-51.51%-11.30%-4.33%-12.89%+24.38%+60.84%-31.25%+298.70%-51.88%
Net margin
0.81%0.92%1.02%2.34%3.02%3.51%4.36%4.17%2.96%4.55%1.13%
Basic shares
120.24M120.45M120.57M123.87M126.42M128.69M132.20M134.05M137.49M144.49M149.37M
Diluted shares
120.93M120.83M120.87M124.44M127.09M129.40M133.01M134.73M138.40M145.58M150.92M
Change in diluted shares
+0.14%-0.04%-2.87%-2.09%-1.78%-2.72%-1.27%-2.66%-4.93%-3.53%-0.15%
EPS (basic)
10.389.8710.0120.0922.2022.7925.4720.1912.2416.944.11
EPS (diluted)
10.279.849.9820.0022.0822.6725.3120.1012.1616.814.07
EPS growth
-3.75%-1.40%-50.10%-9.42%-2.60%-10.43%+25.92%+65.30%-27.66%+313.02%-51.78%
Dividends per share
2.663.543.543.543.152.802.502.202.001.890.87
Dividend growth
-25.00%0.00%0.00%+12.38%+12.50%+12.00%+13.64%+10.00%+5.82%+117.24%-24.35%
EBITDA
3.24B2.91B3.26B4.73B4.81B4.46B5.57B4.29B2.83B-936.00M0.00
EBITDA margin
2.10%2.24%2.76%4.44%5.18%5.33%7.22%6.60%4.96%-1.74%0.00%
EBIT
2.48B2.08B2.29B3.81B3.97B3.75B4.96B3.71B2.29B4.75B2.21B

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

Common questions about Humana's income statement

Source: Financial Modeling Prep